Idogen publishes annual report for 2021
Idogen AB (”Idogen”) has today made the annual report for 2021 public. Idogens annual report is available at the webpage https://www.idogen.com. In the annual report CEO Anders Karlsson comments; ” 2021 was truly a year of successful deliverables – we checked off several important milestones in developing IDO 8 and preparing it for clinical trials. In parallel, we have made advances with IDO T and we are looking forward to making the same journey with our transplantation program.” For further information, please contact: Anders Karlsson, CEO, Idogen AB Phone: